Search results
Results from the WOW.Com Content Network
2010: Endo acquired generic manufacturer Qualitest Pharmaceuticals for $1.2 billion [8] 2011: Endo acquired medical device manufacturer American Medical Systems for more than $2 billion [18] [19] [7] 2013: Endo agreed to purchase Paladin Labs Inc for about $1.6 billion to gain access to the Canadian market as well as expand into emerging markets.
Walmart proposed a $3.1 billion legal settlement on Tuesday over the toll of powerful prescription opioids sold at its pharmacies, becoming the latest major drug industry player to promise major ...
Walmart Inc. v. DEA-DOJ was a settlement involving the complaints and lawsuits of Walmart pharmacy, and other large pharmaceutical companies. The lawsuits were made after an official complaint issued by the United States Department of Justice and the Drug Enforcement Administration, after Walmart was accused of illicitly selling opioids to their customers.
opiate Codeine [2] 9334 opiate Dihydroetorphine [3] 9190 opiate Ethylmorphine [2] 9059 opiate Etorphine hydrochloride [4] 9640 opiate Granulated opium [2] 9193 opiate Hydrocodone [2] 9150 opiate Hydromorphone [2] 9260 opiate Metopon [2] 9300 opiate Morphine [2] 9668 opiate Noroxymorphone [5] 9610 opiate Opium extracts [2] 9620 opiate Opium ...
McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue Pharma. ... at Le Bourget Airport near Paris, France, June ...
The law (TN Code 53-11-311) that prevents nurse practitioners (NPs) or physician assistants (PAs) from prescribing more than 16 milligrams of buprenorphine-naloxone daily (despite standard dosing ...
This is a list of fentanyl analogues (sometimes referred to as Fentalogs), [1] [2] [3] including both compounds developed by pharmaceutical companies for legitimate medical use, and those which have been sold as designer drugs and reported to national drug control agencies such as the DEA, or transnational agencies such as the EMCDDA and UNODC.
McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...